Search Results - "De La Lande, B."

Randomized Phase 2 Study of Whole-Brain Radiation Therapy With or Without Concomitant Temozolomide for Brain Metastases From Breast Cancer by Cao, K.I, Lebas, N, Gerber, S, Levy, C, Fourquet, A, Campana, F, Le Scodan, R, De La Lande, B, Bourgier, C, Pierga, J, Gobillion, A, Savignoni, A, Kirova, Y.M

Get full text

Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer by Pernin, V, Belin, L, Cottu, P, Bontemps, P, Lemanski, C, De La Lande, B, Baumann, P, Missohou, F, Levy, C, Peignaux, K, Reynaud-Bougnoux, A, Denis, F, Gobillion, A, Bollet, M, Vago, N A, Dendale, R, Campana, F, Fourquet, A, Kirova, Y M

“…To evaluate the safety of the concurrent combination of bevacizumab with adjuvant radiotherapy (B-RT) in breast cancer (BC). Multicentre, prospective study, of…”
Get full text

Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study by Dautruche, A., Belin, L., Cottu, P., Bontemps, P., Lemanski, C., de la Lande, B., Baumann, P., Missohou, F., Lévy, C., Peignaux, K., Reynaud-Bougnoux, A., Denis, F., Gobillion, A., Pernin, V., Kirova, Y.

“…To determine the 3 years late toxicity among patients with non-metastatic breast cancer who received concurrent bevacizumab and locoregional radiotherapy. This…”
Get full text

Early and Late Toxicity of Adjuvant Radiation Therapy Associated With Concurrent Bevacizumab in Patients With Breast Cancer by Pernin, V, Belin, L, Cottu, P, Bontemps, P, Lemanski, C, De La Lande, B, Baumann, P, Missohou, F, Levy, C, Kirova, Y

Get full text

Role of Regional Nodal Irradiation in Breast Cancer Patients with Pathologic-negative Lymph Node after Neoadjuvant Chemotherapy and Conservative Surgery by Daveau, C, Stevens, D, Brain, E, Berges, O, Gardner, M, Villette, S, Moisson, P, De la Lande, B, Labib, A, Le Scodan, R

Get full text

Role of lymph node irradiation in breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy: the René-Huguenin Cancer Center experience by Daveau, C, Stevens, D, Labib, A, Berges, O, Moisson, P, De la Lande, B, Le Scodan, R

“…Neoadjuvant chemotherapy generally induces significant changes in the pathological extent of disease. This potential down-staging challenges the standard…”
Get full text

Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience by Le Scodan, R, Bruant, S, Selz, J, Bollet, M-A, Daveau, C, de la Lande, B, Lerebours, F, Labib, A, Stevens, D

“…Neoadjuvant chemotherapy generally induces significant changes in the pathological extent of disease and challenges the standard indications of adjuvant…”
Get full text

Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor) by González González, D, Gerard, J P, Maners, A W, De la Lande-Guyaux, B, Van Dijk-Milatz, A, Meerwaldt, J H, Bosset, J F, Van Dijk, J D

Get more information

OC-0769 Radio-induced lung injury: clinical and dosimetric risk factors in a subset of the CANTO RT cohort by Gueiderikh, A., Sarrade, T., Kirova, Y., De La Lande, B., De Vathaire, F., Auzac, G., Martin, A.L., Everhard, S., Duchemann, B., Allodji, R., Rivera, S.

Get full text

Prognostic value of CA 15.3 kinetics for metastatic breast cancer by DE LA LANDE, B, HACENE, K, FLOIRAS, J.-L, ALATRAKCHI, N, PICHON, M.-F

“…Up to 80% of breast cancer patients developing metastases have high levels of CA 15.3. We studied the prognostic implications of CA 15.3 kinetics in 119…”
Get full text

PO-0942: Post-mastectomy radiotherapy after Immediate versus Two-Stage Breast Reconstruction by Bonzano, E., Guenzi, M., De La Lande, B., Musat, E., Albert-Dufrois, H., Otz, J., Clément-Zhao, A., Filippi, A.R., Corvò, R., Poortmans, P.

Get full text

Long-Term Results of Post Mastectomy Conformal Electron Therapy Technique (PMERT) with Bolus in Comparison with Post Mastectomy Conformal Photon Therapy (PMPhRT) without Bolus in Non-Metastatic Breast Cancer Patients by Boulle, G., Saint Martin, C., Bidoz, N. Fournier, Berger, F., Veret, A., Bragard, C., Minsat, M., Fourquet, A., De La Lande, B., Kirova, Y.

Get full text

Abstract P3-12-06: TOxicities of Locoregional Radiotherapy Associated with Bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation by Clément-Zhao, A, Tanguy, M-L, Cottu, P, De La Lande, B, Bontemps, P, Lemanski, C, Baumann, P, Levy, C, Peignaux, K, Reynaud-Bougnoux, A, Gobillion, A, Kirova, Y

“…Abstract Background and Purpose: Recent phase 3 clinical trials have evaluated the addition of bevacizumab (B) to standard chemotherapy in the treatment of…”
Get full text

OC-0594 Acute toxicity results after breast-conserving therapy in “boost vs no boost (BONBIS)” DCIS trial by Bourgier, C., Cowen, D., Lemanski, C., Castan, F., Rivera, S., De La Lande, B., Peignaux, K., Le Blanc-Onfroy, M., Benyoucef, A., Mege, A., Douadi-Gaci, Z., Racadot, S., Latorzeff, I., Schick, U., Jacquot, S., Massabeau, C., Guilbert, P., Geffrelot, J., Ellis, S., Lecouillard, I., Breton-Callu, C., Richard-Tallet, A., Bontemps, P., Fenoglietto, P., Azria, D.

Get full text

Abstract P1-10-17: Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer by Dautruche, A, Belin, L, Cottu, P, Bontemps, P, Lemanski, C, De La Lande, B, Baumann, P, Missohou, F, Levy, C, Peignaux, K, Reynaud-Bougnoux, A, Denis, F, Gobillion, A, Ady Vago, N, Fourquet, A, Kirova, Y

“…Abstract Purpose/Objectives The purpose of this study was to determine early and late toxicities among patients with non-metastatic breast cancer (BC)…”
Get full text

Abstract P3-06-19: Large-scale retrospective analysis between 1980-2008 in 20 838 women with breast cancer - Results in young women (< 40 years old) by Lerebours, F, Stevens, D, Jouanneau, L, Guerard, A, De La Lande, B, Cherel, P, Lasry, S, Guinebretière, J-M, Noguès, C, Mouret-Fourme, E

“…Abstract Background: The risk for developing breast cancer before the age of 40 is less than 1% and is similar worldwide. Breast cancer in young women is…”
Get full text

Abstract P5-14-11: Locoregional toxicities after adjuvant radiotherapy with or without concurrent bevacizumab in patients with non-metastatic breast cancer by Pernin, V-E, Belin, L, Gobillion, A, Cottu, P, Bontemps, P, Lemanski, C, De La Lande, B, Baumann, P, Missohou, F, Levy, C, Bougnoux, P, Peignaux, K, Denis, F, Kirova, Y

“…Abstract Purpose/Objectives Few data are available regarding the safety of the concurrent combination of bevacizumab with adjuvant radiotherapy (RT) in breast…”
Get full text

Spinal stereotactic body radiotherapy: French assessment in 2016 by Pougnet, I, Jaegle, E, Garcia, R, Tessier, F, Faivre, J C, Louvel, G, Gross, E, Gonzague, L, Benchalal, M, Ducteil, A, Supiot, S, Autret, D, Clavier, J B, Mirabel, X, Bellière, A, Wdowczyk, D, Heymann, S, Barillot, I, de La Lande, B, Passerat, V, Sunyach, M P, Lipinski, F, Thibouw, D, Guichard, F, Chauvet, B, Thariat, J, Arnaud, A

“…Stereotactic body radiotherapy to vertebral column remains uncommon practice and only relevant in selected group of patients. The main objective of the study…”
Get full text

Adjuvant chemotherapy and lymph node irradiation in breast cancer patients with axillary lymph node micrometastases or isolated tumor cells by Gardner, M., Stevens, D., Zilberman, S., Villette, S., Lerebours, F., Moisson, P., De La Lande, B., Le Scodan, R., Guinebretiere, J., Labib, A.

“…Abstract only…”
Get full text

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results by Rouëssé, Jacques, de la Lande, Brigitte, Bertheault-Cvitkovic, Frédérique, Serin, Daniel, Graïc, Yvon, Combe, Martin, Leduc, Bernard, Lucas, Virginie, Demange, Liliane, Nguyen, Tan Dat, Castèra, Daniel, Krzisch, Claude, Villet, Richard, Mouret-Fourme, Emmanuelle, Garbay, Jean-Rémy, Noguès, Catherine

“…To compare concomitant and sequential adjuvant chemoradiotherapy regimens in node-positive, operable breast cancer patients. This was a randomized, French,…”
Get more information